Condition | Cancer

ALLIANCE A081105

  • IRB Number: ALLIANCE A081105
  • Contact Name: Rachel O'Loughlin, RN BSN
  • Status: Enrolling
  • Phone: (585) 747-4555
  • Lead Researcher: Mehul Patel, MD

Description

Randomized Study of Erlotinib vs Observation In Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)

https://clinicaltrials.gov/ct2/show/NCT02193282